ETM-ANN Approach Application for Thiobenzamide and Quinolizidine Derivatives

Figure 7

Frequency of the fragments’ occurrencies in the compounds studied: (a) for Pharmacophores P1, P2, and P3; (b) for antipharmacophores AP1, AP2, and AP3.

(a)

(b)